NZ's AFT Pharmaceuticals gains most in 4 months on FY26 earnings outlook upgrade

AFT Pharmaceuticals

07/04/2026 04:43

** Shares of New Zealand's AFT Pharmaceuticals AFT.NZ rise as much as 4.2% to NZ$3.5, their biggest intraday pct gain since December 4

** Stock hits its highest level since March 23

** The pharmaceutical distributor lifts FY26 operating earnings outlook to NZ$20 million-NZ$24 million ($13.67 million), up from NZ$12 million last year

** Co announces partnership with U.S.-based pharma company Cost Plus, which is backed by billionaire Mark Cuban, for distribution of its Maxigesic Rapid tablets

** Stock up 3.3% YTD, including day's moves

($1 = 1.7553 New Zealand dollars)

 (Reporting by Aamir Sheik Khalid in Bengaluru)

 ((Aamir.SheikKhalid@thomsonreuters.com))